Yamazaki H, Inoue K, Mimura M, Oda Y, Guengerich F P, Shimada T
Osaka Prefectural Institute of Public Health, Japan.
Biochem Pharmacol. 1996 Feb 9;51(3):313-9. doi: 10.1016/0006-2952(95)02178-7.
7-Ethoxycoumarin O-deethylation has been used widely as a marker activity for assessing substrate specificities of cytochromes P450 (P450) in liver microsomes of mammals, and extensive studies have shown that in rats and mice the major catalysts are P450 1A1, 1A2, and 2B enzymes. In contrast to findings in experimental animal models, P450 2E1 has been reported to be a principal enzyme involved in 7-ethoxy-coumarin O-deethylation in human livers. In this study, we further examined the roles of individual forms of human P450 involved in 7-ethoxycoumarin O-deethylation using microsomes from different human liver samples and from human lymphoblastoid cells expressing human P450 enzymes and purified P450 enzymes isolated from the membrane of Escherichia coli expressing modified P450 proteins. Kinetic analysis showed that there were at least two different enzymes involved in 7-ethoxycoumarin O-deethylation in different human samples. Samples that contained high amounts of P450 2E1 in liver microsomes showed biphasic curves for O-deethylation with relatively high turnover numbers, whereas P450 1A2-rich samples tended to have low Km values with low Vmax values. Anti-human P450 2E1 antibodies inhibited markedly (P < 0.05) the 7-ethoxycoumarin O-deethylation activities catalyzed by human liver microsomes particularly when examined at a high substrate concentration (200 microM). However, we also found that anti-P450 1A2 antibodies suppressed O-deethylation activities only at a low substrate concentration (10 microM). Recombinant human P450 1A2 was found to have a low Km value for 7-ethoxycoumarin O-deethylation, whereas P450 2E1 showed a high Km value. Of the P450 enzymes examined, P450 1A1 gave the highest O-deethylation activities with a low Km value, although this enzyme is reported to be expressed extrahepatically in humans. Other human P450 enzymes, including P450 2A6, 2C10, 2D6, 3A4, and 3A5, did not show significant O-deethylation activities except that P450 2B6, a minor P450 component in human livers, was found to have a Vmax value similar to that of P450 1A2 and a Km value similar to that of P450 2E1. These results suggest that P450 1A2 is a low Km enzyme for 7-ethoxycoumarin O-deethylation in human liver microsome, although it has a low Vmax value than P450 2E1.
7-乙氧基香豆素O-脱乙基作用已被广泛用作评估哺乳动物肝微粒体中细胞色素P450(P450)底物特异性的标记活性,大量研究表明,在大鼠和小鼠中,主要的催化剂是P450 1A1、1A2和2B酶。与实验动物模型中的发现相反,据报道P450 2E1是参与人肝脏中7-乙氧基香豆素O-脱乙基作用的主要酶。在本研究中,我们使用来自不同人肝脏样本、表达人P450酶的人淋巴母细胞以及从表达修饰P450蛋白的大肠杆菌膜中分离的纯化P450酶的微粒体,进一步研究了参与7-乙氧基香豆素O-脱乙基作用的人P450各形式的作用。动力学分析表明,在不同的人样本中,至少有两种不同的酶参与7-乙氧基香豆素O-脱乙基作用。肝微粒体中含有大量P450 2E1的样本显示O-脱乙基作用的双相曲线,周转数相对较高,而富含P450 1A2的样本往往具有低Km值和低Vmax值。抗人P450 2E1抗体显著抑制(P<0.05)人肝微粒体催化的7-乙氧基香豆素O-脱乙基活性,特别是在高底物浓度(200 microM)下检测时。然而,我们还发现抗P450 1A2抗体仅在低底物浓度(10 microM)下抑制O-脱乙基活性。发现重组人P450 1A2对7-乙氧基香豆素O-脱乙基作用的Km值较低,而P450 2E1显示出较高的Km值。在所检测的P450酶中,P450 1A1具有最高的O-脱乙基活性和低Km值,尽管据报道该酶在人体中肝外表达。其他人类P450酶,包括P450 2A6、2C10、2D6、3A4和3A5,未显示出显著的O-脱乙基活性,除了人肝脏中次要的P450成分P450 2B6,其Vmax值与P450 1A2相似,Km值与P450 2E1相似。这些结果表明,P450